These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2120422)

  • 1. Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species and isolated perfused rat liver.
    Tanswell P; Heinzel G; Greischel A; Krause J
    J Pharmacol Exp Ther; 1990 Oct; 255(1):318-24. PubMed ID: 2120422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total body and hepatic clearance in rats of recombinant tissue-type plasminogen activator expressed in mouse C127 and Chinese hamster ovary cells.
    Hori R; He YL; Shima T; Inui K; Aoki S; Okumura K; Tanigawara Y
    Drug Metab Dispos; 1992; 20(4):541-6. PubMed ID: 1356732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clearance of t-PA, PAI-1, and t-PA-PAI-1 complex in an isolated perfused rat liver system.
    Wing LR; Hawksworth GM; Bennett B; Booth NA
    J Lab Clin Med; 1991 Feb; 117(2):109-14. PubMed ID: 1899689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic clearance of tissue-type plasminogen activator in rats.
    Emeis JJ; van den Hoogen CM; Jense D
    Thromb Haemost; 1985 Oct; 54(3):661-4. PubMed ID: 3937264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance of tissue plasminogen activator by mannose and galactose receptors in the liver.
    Smedsrød B; Einarsson M
    Thromb Haemost; 1990 Feb; 63(1):60-6. PubMed ID: 2160132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver blood flow as a major determinant of the clearance of recombinant human tissue-type plasminogen activator.
    de Boer A; Kluft C; Kroon JM; Kasper FJ; Schoemaker HC; Pruis J; Breimer DD; Soons PA; Emeis JJ; Cohen AF
    Thromb Haemost; 1992 Jan; 67(1):83-7. PubMed ID: 1615490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and hepatic catabolism of tissue-type plasminogen activator.
    Tanswell P; Seifried E; Stang E; Krause J
    Arzneimittelforschung; 1991 Dec; 41(12):1310-9. PubMed ID: 1815534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocytosis of the recombinant tissue plasminogen activator alteplase by hepatic endothelial cells.
    Seydel W; Stang E; Roos N; Krause J
    Arzneimittelforschung; 1991 Feb; 41(2):182-6. PubMed ID: 1904231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the low-density lipoprotein receptor-related protein (LRP) in the plasma clearance and liver uptake of recombinant single-chain urokinase-type plasminogen activator in rats.
    van der Kaaden ME; Rijken DC; Kruijt JK; van Berkel TJ; Kuiper J
    Thromb Haemost; 1997 Apr; 77(4):710-7. PubMed ID: 9134648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An experimental multiple-organ model for the study of regional net release/uptake rates of tissue-type plasminogen activator in the intact pig.
    Jern C; Seeman-Lodding H; Biber B; Winsö O; Jern S
    Thromb Haemost; 1997 Sep; 78(3):1150-6. PubMed ID: 9308769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonlinear pharmacokinetics of a recombinant human granulocyte colony-stimulating factor derivative (nartograstim): species differences among rats, monkeys and humans.
    Kuwabara T; Kato Y; Kobayashi S; Suzuki H; Sugiyama Y
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1535-43. PubMed ID: 7527856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of increased liver blood flow on the kinetics and dynamics of recombinant tissue-type plasminogen activator.
    van Griensven JM; Huisman LG; Stuurman T; Dooijewaard G; Kroon R; Schoemaker RC; Kluft K; Cohen AF
    Clin Pharmacol Ther; 1996 Nov; 60(5):504-11. PubMed ID: 8941023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Internalization of recombinant tissue-type plasminogen activator by isolated rat hepatocytes is via coated pits.
    Marks GJ; Hart TK; Rush GF; Hoffstein ST; Fong KL; Bugelski PJ
    Thromb Haemost; 1990 Apr; 63(2):251-8. PubMed ID: 1973006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of liver blood flow on the pharmacokinetics of tissue-type plasminogen activator (alteplase) during thrombolysis in patients with acute myocardial infarction.
    van Griensven JM; Koster RW; Burggraaf J; Huisman LG; Kluft C; Kroon R; Schoemaker RC; Cohen AF
    Clin Pharmacol Ther; 1998 Jan; 63(1):39-47. PubMed ID: 9465840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the interaction of a complex of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 with rat liver cells.
    Kuiper J; Otter M; Voorschuur AH; van Zonneveld AJ; Rijken DC; van Berkel TJ
    Thromb Haemost; 1995 Nov; 74(5):1298-304. PubMed ID: 8607113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
    Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cluster mannosides can inhibit mannose receptor-mediated tissue-type plasminogen activator degradation by both rat and human cells.
    Noorman F; Barrett-Bergshoeff MM; Biessen EA; van de Bilt E; van Berkel TJ; Rijken DC
    Hepatology; 1997 Nov; 26(5):1303-10. PubMed ID: 9362376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.
    Warshawsky I; Bu G; Schwartz AL
    J Clin Invest; 1993 Aug; 92(2):937-44. PubMed ID: 8349826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant variants of tissue-type plasminogen activator containing amino acid substitutions in the fibronectin finger-like domain and the kringle 1 domain.
    Yahara H; Matsumoto K; Maruyama H; Nagaoka T; Ikenaka Y; Yajima K; Fukao H; Ueshima S; Matsuo O
    Thromb Haemost; 1994 Dec; 72(6):893-9. PubMed ID: 7740460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elimination of native and carbohydrate-modified tissue plasminogen activator in rabbits.
    Einarsson M; Hggroth L; Mattsson C
    Thromb Haemost; 1989 Dec; 62(4):1088-93. PubMed ID: 2515604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.